Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.H.S., Duke University 2005
  • Fellowship, Gastroenterology, Duke University School of Medicine 1990 - 1993
  • Resident, Duke University School of Medicine 1988 - 1990
  • Intern, Duke University School of Medicine 1987 - 1988
  • M.D., George Washington University 1987
• 

  Duke Appointment History

  • Associate Professor of Medicine, Medicine, Gastroenterology, Medicine 2006 - 2008
  • Assistant Professor of Medicine, Medicine, Gastroenterology, Medicine 1998 - 2006
  • Assistant Clinical Professor of Medicine, Medicine, Gastroenterology, Medicine 1995 - 1998
  • Associate in the Department of Medicine, Medicine, Gastroenterology, Medicine 1993 - 1995
• Research
• 

  Selected Grants

  • Moderate to Severe Crohn's Disease 2018 - 2022
  • Boehringer Ingelheim Pharmaceuticals Inc - Industry - BI 655130 in Ulcerative Colitis Subjects 2019 - 2020
  • DG29 SERES 2019 - 2020
  • GS-US-326-1100 Dr. Onken Study 2015 - 2017
  • The Role of NAG-1 in Inflammatory Bowel Disease awarded by National Institute of Environmental Health Sciences 2008 - 2010
  • Bromelain as a Biologically-Based Therapy for IBD awarded by National Institutes of Health 2004 - 2007
• 

  Industry Relationships

  • American Board of Internal Medicine
  • American Gastroenterological Association (AGA)
  • Boehringer Ingleheim
  • Janssen Pharmaceuticals (Johnson & Johnson)
  • Schering-Plough Corp. (owned by Merck & Co, USA)
  • Seres
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Lichtenstein, Gary R., and Jane E. Onken. “Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron..” Dig Dis Sci 63, no. 11 (November 2018): 3009–19. https://doi.org/10.1007/s10620-018-5204-3.
       Full Text  Link to Item
    • Sandborn, W. J., B. R. Bhandari, R. Fogel, J. Onken, E. Yen, X. Zhao, Z. Jiang, et al. “Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis..” Aliment Pharmacol Ther 44, no. 2 (July 2016): 157–69. https://doi.org/10.1111/apt.13653.
       Full Text  Link to Item
    • Regueiro, Miguel, Brian G. Feagan, Bin Zou, Jewel Johanns, Marion A. Blank, Marc Chevrier, Scott Plevy, et al. “Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection..” Gastroenterology 150, no. 7 (June 2016): 1568–78. https://doi.org/10.1053/j.gastro.2016.02.072.
       Full Text  Link to Item
    • Roe, Matthew T., Derek D. Cyr, Debra Eckart, Phillip J. Schulte, Michael A. Morse, Kimberly L. Blackwell, Neal E. Ready, et al. “Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome..” Eur Heart J 37, no. 4 (January 21, 2016): 412–22. https://doi.org/10.1093/eurheartj/ehv611.
       Full Text  Link to Item
    • Rose, Suzanne, Brijen J. Shah, Jane Onken, Arthur J. DeCross, Maura H. Davis, Rajeev Jain, Lawrence S. Kim, Kim Persley, Sheryl A. Pfeil, and Lori N. Marks. “Bridging the G-APP: Continuous Professional Development for Gastroenterologists: Replacing MOC with a Model for Lifelong Learning and Accountability..” Clin Gastroenterol Hepatol, August 19, 2015. https://doi.org/10.1016/j.cgh.2015.08.016.
       Full Text  Link to Item
    • Rose, Suzanne, Brijen J. Shah, Jane Onken, Arthur J. DeCross, Maura H. Davis, Rajeev Jain, Lawrence S. Kim, Kim Persley, Sheryl A. Pfeil, and Lori N. Marks. “Bridging the G-APP: Continuous Professional Development for Gastroenterologists: Replacing MOC with a Model for Lifelong Learning and Accountability..” Gastroenterology, August 19, 2015. https://doi.org/10.1053/j.gastro.2015.08.009.
       Full Text  Link to Item
    • Onken, Jane E., and Arthur J. DeCross. “The education and training committee: at work for the AGA membership..” Gastroenterology 147, no. 5 (November 2014): 948–51. https://doi.org/10.1053/j.gastro.2014.09.022.
       Full Text  Link to Item
    • Oversight Working Network, Robert E., Suzanne Rose, Oren K. Fix, Brijen J. Shah, Tamara N. Jones, Ronald D. Szyjkowski, Brian P. Bosworth, et al. “Entrustable professional activities for gastroenterology fellowship training..” Gastrointest Endosc 80, no. 1 (July 2014): 16–27. https://doi.org/10.1016/j.gie.2014.05.302.
       Full Text  Link to Item
    • Onken, Jane E., David B. Bregman, Robert A. Harrington, David Morris, John Buerkert, Douglas Hamerski, Hussain Iftikhar, et al. “Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial..” Nephrol Dial Transplant 29, no. 4 (April 2014): 833–42. https://doi.org/10.1093/ndt/gft251.
       Full Text  Link to Item
    • Onken, Jane E., David B. Bregman, Robert A. Harrington, David Morris, Peter Acs, Bruce Akright, Charles Barish, et al. “A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia..” Transfusion 54, no. 2 (February 2014): 306–15. https://doi.org/10.1111/trf.12289.
       Full Text  Link to Item
    • Roe, Matthew T., Paul W. Armstrong, Keith A. A. Fox, Harvey D. White, Dorairaj Prabhakaran, Shaun G. Goodman, Jan H. Cornel, et al. “Prasugrel versus clopidogrel for acute coronary syndromes without revascularization..” N Engl J Med 367, no. 14 (October 4, 2012): 1297–1309. https://doi.org/10.1056/NEJMoa1205512.
       Full Text  Link to Item
    • Szczech, Lynda A., David B. Bregman, Robert A. Harrington, David Morris, Angelia Butcher, Todd A. Koch, Lawrence T. Goodnough, Myles Wolf, and Jane E. Onken. “Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design..” Nephrol Dial Transplant 25, no. 7 (July 2010): 2368–75. https://doi.org/10.1093/ndt/gfq218.
       Full Text  Link to Item
    • Onken, Jane E. “Is colorectal cancer surveillance cost-effective in patients with ulcerative colitis?.” Inflamm Bowel Dis 14 Suppl 2 (October 2008): S196–97. https://doi.org/10.1002/ibd.20613.
       Full Text  Link to Item
    • Hampton, Daniel D., Martin H. Poleski, and Jane E. Onken. “Inflammatory bowel disease following solid organ transplantation..” Clin Immunol 128, no. 3 (September 2008): 287–93. https://doi.org/10.1016/j.clim.2008.06.011.
       Full Text  Link to Item
    • Onken, Jane E., Paula K. Greer, Brian Calingaert, and Laura P. Hale. “Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro..” Clin Immunol 126, no. 3 (March 2008): 345–52. https://doi.org/10.1016/j.clim.2007.11.002.
       Full Text  Link to Item
    • Micames, Carlos G., Rex Bentley, and Jane Onken. “Clinical challenges and images in GI. Invasive candidal enterocolitis..” Gastroenterology 133, no. 2 (August 2007): 391–731. https://doi.org/10.1053/j.gastro.2007.06.051.
       Full Text  Link to Item
    • Arseneau, Kristen O., Shahnaz Sultan, Dawn T. Provenzale, Jane Onken, Stephen J. Bickston, Eugene Foley, Alfred F. Connors, and Fabio Cominelli. “Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis?.” Clin Gastroenterol Hepatol 4, no. 9 (September 2006): 1135–42. https://doi.org/10.1016/j.cgh.2006.05.003.
       Full Text  Link to Item
    • Hampton, D., and J. E. Onken. “Pulmonary eosinophilia following infliximab treatment for Crohn's disease: Review.” Gastroenterology and Hepatology 2, no. 8 (August 1, 2006).
    • Hampton, Daniel, and Jane E. Onken. “Review..” Gastroenterol Hepatol (N Y) 2, no. 8 (August 2006).
       Link to Item
    • Provenzale, Dawn, and Jane E. Onken. “TPMT genotype screening for patients about to begin azathioprine treatment--a look at costs and potential benefits..” Inflamm Bowel Dis 11, no. 12 (December 2005): 1119–20. https://doi.org/10.1097/01.mib.0000186491.43191.0e.
       Full Text  Link to Item
    • Emmons, Karen M., Colleen M. McBride, Elaine Puleo, Kathryn I. Pollak, Elizabeth Clipp, Karen Kuntz, Bess H. Marcus, et al. “Project PREVENT: a randomized trial to reduce multiple behavioral risk factors for colon cancer..” Cancer Epidemiol Biomarkers Prev 14, no. 6 (June 2005): 1453–59. https://doi.org/10.1158/1055-9965.EPI-04-0620.
       Full Text  Link to Item
    • Emmons, Karen M., Colleen M. McBride, Elaine Puleo, Kathryn I. Pollak, Bess H. Marcus, Melissa Napolitano, Elizabeth Clipp, Jane Onken, Francis A. Farraye, and Robert Fletcher. “Prevalence and predictors of multiple behavioral risk factors for colon cancer..” Prev Med 40, no. 5 (May 2005): 527–34. https://doi.org/10.1016/j.ypmed.2004.10.001.
       Full Text  Link to Item
    • Sands, Bruce E., Carmen Cuffari, Jeffry Katz, Subra Kugathasan, Jane Onken, Charles Vitek, and Walter Orenstein. “Guidelines for immunizations in patients with inflammatory bowel disease..” Inflamm Bowel Dis 10, no. 5 (September 2004): 677–92. https://doi.org/10.1097/00054725-200409000-00028.
       Full Text  Link to Item
    • Clipp, Elizabeth C., Elizabeth H. Carver, Kathryn I. Pollak, Elaine Puleo, Karen M. Emmons, Jane Onken, Francis A. Farraye, and Colleen M. McBride. “Age-related vulnerabilities of older adults with colon adenomas: evidence from Project Prevent..” Cancer 100, no. 5 (March 1, 2004): 1085–94. https://doi.org/10.1002/cncr.20082.
       Full Text  Link to Item
    • Sands, Bruce E., Frank H. Anderson, Charles N. Bernstein, William Y. Chey, Brian G. Feagan, Richard N. Fedorak, Michael A. Kamm, et al. “Infliximab maintenance therapy for fistulizing Crohn's disease..” N Engl J Med 350, no. 9 (February 26, 2004): 876–85. https://doi.org/10.1056/NEJMoa030815.
       Full Text  Link to Item
    • Bloomfeld, R. S., and J. E. Onken. “Mercaptopurine metabolite results in clinical gastroenterology practice..” Aliment Pharmacol Ther 17, no. 1 (January 2003): 69–73. https://doi.org/10.1046/j.1365-2036.2003.01392.x.
       Full Text  Link to Item
    • Onken, Jane E., Joëlle Y. Friedman, Sujha Subramanian, Kevin P. Weinfurt, Shelby D. Reed, Joshua H. Malenbaum, Troy Schmidt, and Kevin A. Schulman. “Treatment patterns and costs associated with sessile colorectal polyps..” Am J Gastroenterol 97, no. 11 (November 2002): 2896–2901. https://doi.org/10.1111/j.1572-0241.2002.07058.x.
       Full Text  Link to Item
    • Hanauer, S. B., B. G. Feagan, G. R. Lichtenstein, and J. E. Onken. “Maintaining remission in Crohn's Disease.” Evidence Based Gastroenterology 3, no. 3 (August 1, 2002): 99–101. https://doi.org/10.1097/00132579-200208000-00013.
       Full Text
    • Bloomfeld, Richard S., and Jane E. Onken. “6-Mercaptopurine (6MP) metabolite measurements from the clinics: The first year of widespread availability.” Gastroenterology 120, no. 5 (April 2001): A626–A626. https://doi.org/10.1016/s0016-5085(08)83114-9.
       Full Text
    • Provenzale, D., and J. Onken. “Surveillance issues in inflammatory bowel disease: ulcerative colitis..” J Clin Gastroenterol 32, no. 2 (February 2001): 99–105. https://doi.org/10.1097/00004836-200102000-00003.
       Full Text  Link to Item
    • Muir, Andrew J., Dawn Provenzale, and Jane E. Onken. “Fistulous complications in Crohn's disease: Impact on health related quality of life (HRQL) and resource utilization.” Gastroenterology 118, no. 4 (April 2000): A585–A585. https://doi.org/10.1016/s0016-5085(00)84477-7.
       Full Text
    • Onken, J. E., B. Sands, R. Hogezand, G. Haens, T. Braakman, K. DeWoody, T. Schaible, et al. “Consistent treatment benefit with infliximab in patients with fistulizing Crohn's disease.” Gastroenterology 116, no. 4 (April 1, 1999): A788–A788.
       Link to Item
    • Eloubeidi, M. A., and J. E. Onken. “Manifestations of Crohn's disease..” Dig Dis 16, no. 4 (July 1998). https://doi.org/10.1159/000016874.
       Full Text  Link to Item
    • Provenzale, D., J. B. Wong, J. E. Onken, and J. Lipscomb. “Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis..” Am J Gastroenterol 93, no. 6 (June 1998): 872–80. https://doi.org/10.1111/j.1572-0241.1998.00314.x.
       Full Text  Link to Item
    • Provenzale, D., M. Shearin, J. E. Onken, and J. B. Wong. “Surveillance with colectomy for low grade dysplasia increases length and quality of life in ulcerative colitis patients and is cost-effective compared with common medical practices.” Gastroenterology 114 (April 1998): A35–A35. https://doi.org/10.1016/s0016-5085(98)80142-x.
       Full Text
    • Ciaccia, D., F. Gress, J. E. Onken, J. Feczko, J. Chappo, and G. Lehman. “Endoscopic ultrasound characteristics in chronic pancreatitis.” Gastrointestinal Endoscopy 45, no. 4 (April 1, 1997): 582–582.
       Link to Item
    • Davis, W. Z., P. B. Cotton, R. Arias, D. Williams, and J. E. Onken. “ERCP and sphincterotomy in the context of laparoscopic cholecystectomy: academic and community practice patterns and results..” Am J Gastroenterol 92, no. 4 (April 1997): 597–601.
       Link to Item
    • Onken, J. E., D. Ciaccia, J. T. Garbutt, and T. L. Ortel. “Activated protein C resistance (APCR) phenotype in patients with inflammatory bowel disease..” Gastroenterology 112, no. 4 (April 1, 1997): A1056–A1056.
       Link to Item
    • Ciaccia, D., J. Onken, J. Chappo, S. Sherman, G. Lehman, and F. Gress. “Endoscopic ultrasound guided fine needle aspiration in the diagnosis of chronic pancreatitis (CP).” Gastrointestinal Endoscopy 45, no. 4 (January 1, 1997). https://doi.org/10.1016/S0016-5107(97)80582-2.
       Full Text
    • Jowell, P. S., G. Eisen, J. Onken, B. P. Bute, and B. Ginsberg. “Patient-controlled analgesia for conscious sedation during endoscopic retrograde cholangiopancreatography: a randomized controlled trial..” Gastrointest Endosc 43, no. 5 (May 1996): 490–94. https://doi.org/10.1016/s0016-5107(96)70292-4.
       Full Text  Link to Item
    • Bouras, E. P., K. M. McGrath, D. Ciaccia, and J. E. Onken. “Correlation of common bile duct diameter by ultrasound and cholangiography..” Gastrointestinal Endoscopy 43, no. 4 (April 1, 1996): 337–337.
       Link to Item
    • Onken, J. E., S. R. Brazer, G. M. Eisen, D. M. Williams, E. P. Bouras, E. R. DeLong, T. T. Long, F. S. Pancotto, D. L. Rhodes, and P. B. Cotton. “Predicting the presence of choledocholithiasis in patients with symptomatic cholelithiasis..” Am J Gastroenterol 91, no. 4 (April 1996): 762–67.
       Link to Item
    • Provenzale, D., J. E. Onken, and J. B. Wong. “Prophylactic colectomy or surveillance for patients with ulcerative colitis - A cost-effectiveness analysis..” Gastroenterology 110, no. 4 (April 1, 1996): A34–A34.
       Link to Item
    • Bouras, E. P., K. M. McGrath, D. Ciaccia, and J. E. Onken. “Correlation of common bile duct diameter by ultrasound and cholangiography.” Gastrointestinal Endoscopy 43, no. 4 (January 1, 1996). https://doi.org/10.1016/S0016-5107(96)80338-5.
       Full Text
    • Strobel, J., M. Eloubeidi, and J. Onken. “Clinical factors predicting good outcome in upper gastrointestinal bleeding.” Gastrointestinal Endoscopy 43, no. 4 (January 1, 1996). https://doi.org/10.1016/S0016-5107(96)80123-4.
       Full Text
    • Onken, J. E., E. P. Bouras, D. M. Williams, and S. R. Brazer. “Liver test patterns as predictors of choledocholithiasis.” Gastrointestinal Endoscopy 41, no. 4 (April 1995): 409–409. https://doi.org/10.1016/s0016-5107(05)80490-0.
       Full Text
    • Brazer, S. R., J. E. Onken, C. B. Dalton, J. W. Smith, and S. S. Schiffman. “Effect of different coffees on esophageal acid contact time and symptoms in coffee-sensitive subjects..” Physiol Behav 57, no. 3 (March 1995): 563–67. https://doi.org/10.1016/0031-9384(94)00363-a.
       Full Text  Link to Item
    • Onken, J. E., and S. R. Brazer. “Clinical trials. How should they be designed?.” Gastrointest Endosc Clin N Am 4, no. 2 (April 1994): 423–34.
       Link to Item
    • BRAZER, S. R., J. E. ONKEN, C. B. DALTON, J. W. SMITH, and S. S. SCHIFFMAN. “THE EFFECT OF DIFFERENT COFFEES ON ESOPHAGEAL ACID CONTACT TIME (EACT), HEARTBURN (HB) AND REGURGITATION (RG) IN COFFEE-SENSITIVE SUBJECTS.” Gastroenterology 104, no. 4 (April 1, 1993): A45–A45.
       Link to Item
    • ONKEN, J. E., S. R. BRAZER, F. S. PANCOTTO, T. T. LONG, D. F. RHODES, and P. B. COTTON. “PREDICTION OF CHOLEDOCHOLITHIASIS.” Gastroenterology 104, no. 4 (April 1, 1993): A19–A19.
       Link to Item
    • Onken, J. E., and J. Baillie. “A prospective study of esophageal squamous cell carcinoma in achalasia..” Gastrointest Endosc 38, no. 6 (November 1992): 738–39. https://doi.org/10.1016/s0016-5107(92)70596-3.
       Full Text  Link to Item
    • Onken, J. E., T. Pappas, and J. Baillie. “Long term results of choledochoduodenostomy in the treatment of choledocholithiasis..” Gastrointest Endosc 38, no. 3 (May 1992): 403–5. https://doi.org/10.1016/s0016-5107(92)70459-3.
       Full Text  Link to Item

  • Conference Papers

    • Fasanya-Uptagraft, Helen, Jeffrey Basile, Ashley Lane, Harold J. Boutte, and Jane E. Onken. “Outcomes of Inflammatory Bowel Disease After Organ Transplantation (Solid Organ or Hematopoietic Stem Cell Transplantation).” In Gastroenterology, 146:S445–S445. W B SAUNDERS CO-ELSEVIER INC, 2014.
       Link to Item
    • Lichtenstein, Gary R., Andy He, B. Hanauer, Satish Keshav, and Jane E. Onken. “Ferric Carboxymaltose: Efficacy and Safety in Patients With Gastrointestinal-Related Iron Deficiency Anemia: A Pooled Analysis.” In Gastroenterology, 146:S369–S369. W B SAUNDERS CO-ELSEVIER INC, 2014.
       Link to Item
    • Hale, L. P., M. R. Gottfried, and J. E. Onken. “Bromelain treatment of inflammatory bowel disease.” In Gastroenterology, 126:A286–87. W B SAUNDERS CO, 2004.
       Link to Item
    • Parent, J., M. S. Branch, P. S. Jowell, J. Affronti, J. Onken, T. Pappas, and J. Baillie. “Predictors of improvement following endoscopic management of chronic pancreatitis.” In Gastrointestinal Endoscopy, Vol. 43, 1996.

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.